✦ LIBER ✦

Reexamination of the need for treatment in idiopathic thrombocytopenic purpura

✍ Scribed by Michael Auerbach; Harold Ballard

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 338 KB
Volume: 81
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Splenectomy in the treatment of idiopath

Splenectomy in the treatment of idiopathic thrombocytopenic purpura

✍ P. L. Brooks; M. J. O'Shea; J. P. Pryor 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Slow infusion of vincristine in the trea

Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura

✍ Dr. Arumugam Manoharan 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Slow infusion of vincristine in the trea

Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura

✍ M. M. Reld; A. Manoharan 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

Rituximab for the treatment of refractor

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases

✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp

Treatment, outcome, and cost of care in

Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura

✍ Manjusha Kumar; Terry A. Vik; Cynthia S. Johnson; M. Elaine Southwood; James M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

Intravenous gammaglobulin (Gamimune) for

Intravenous gammaglobulin (Gamimune) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): A two-year follow-up

✍ Indira A. Warrier; Jeanne M. Lusher 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 1 views

Thirteen subjects 5-20 years of age with the chronic, autoimmune form of idiopathic thrombocytopenic purpura (ITP) were given intravenous gammaglobulin (Gamimune; Cutter Biological, Berkeley, CA) in a dose of 400 mg/kg per day for 5 consecutive days. Two of the 13 children had undergone splenectomy;